title: Vascular kallikrein in deoxycorticosterone acetate-salt hypertensive rats.
abstract: We determined the status of vascular kallikrein in rats with severe hypertension caused by treatment with deoxycorticosterone acetate (DOCA) and drinking of 1% NaCl for 6 weeks. We assayed active and total kininogenase (kallikrein) activity in the perfusate and in arterial and venous tissue. DOCA-salt rats had higher systolic blood pressure at 6 weeks (214 +/- 5 mm Hg) than rats drinking tap water (135 +/- 4 mm Hg) or saline (145 +/- 8 mm Hg). Kininogenase in the perfusate (nanograms bradykinin per minute per kilogram body weight) increased significantly at 2 weeks, from 5.8 +/- 2.1 to 8.9 +/- 1.4 for active kallikrein and from 28.7 +/- 0.4 to 48.7 +/- 2.9 for total kallikrein. Total kallikrein returned to control values at 4 weeks, whereas it was significantly reduced at 6 weeks (20.9 +/- 0.7). Active kallikrein was significantly depressed at 4 and 6 weeks (1.08 +/- 0.1 and 0.85 +/- 0.1, respectively [P < .05]). Active kallikrein in arterial tissue (picograms bradykinin per milligram per minute) showed a small but significant increase at 2 weeks, from 156 +/- 7 to 201 +/- 10 (P < .05), finally decreasing significantly by 6 weeks to 64 +/- 3; however, total kallikrein showed a significant decrease only at 6 weeks, from 844 +/- 17 to 427 +/- 27. Both active and total kallikrein in the veins were higher than control values at 2 weeks, changing from 437 +/- 7 to 541 +/- 19 and from 1619 +/- 17 to 2062 +/- 86, respectively. Venous kallikrein remained elevated until the end of the experiment.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Argentine Council of Research (CONICET), School of Medicine, UNC, Mendoza.
authors.forename: H
authors.initials: H
authors.lastname: Nolly
authors.forename: O A
authors.initials: OA
authors.lastname: Carretero
authors.forename: M C
authors.initials: MC
authors.lastname: Lama
authors.forename: R
authors.initials: R
authors.lastname: Miatello
authors.forename: A G
authors.initials: AG
authors.lastname: Scicli
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001012:Aorta, Abdominal / Q000201:enzymology; D001013:Aorta, Thoracic / Q000201:enzymology; D003900:Desoxycorticosterone; D006973:Hypertension / Q000139:chemically induced / Q000201:enzymology*; D007610:Kallikreins / Q000378:metabolism*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology*; D051381:Rats; D017208:Rats, Wistar; D012982:Sodium, Dietary; D013997:Time Factors; D014680:Veins / Q000201:enzymology; D014682:Vena Cava, Inferior / Q000201:enzymology
chemical_list: D012982:Sodium, Dietary; D003900:Desoxycorticosterone; D007610:Kallikreins